The Community Screening Interview for Dementia (CSI-D) has been widely used for dementia research among aging adults in low- and middle-income countries, where few specialists are available to diagnose and manage dementia. Yet, little is known about the psychometric validity of the participant interview, particularly a...
L. Kalungwana, Nicholas Heaton, E. Briceño et al.· npj Dementia· 0 citations
Background More than 90% of rare diseases lack an approved therapy, partly reflecting economic barriers in developing treatments for small patient populations. A common bottleneck is costly and resource-intensive hit-to-lead prioritization. Congenital contractures of the limbs and face, hypotonia, and developmental del...
N. Thongsepee, Jeremy A. Tanner, Srikanth R. Polusani et al.· bioRxiv· 0 citations
Background Identifying candidate biomarkers for preclinical dementia could improve our understanding of underlying biological pathways leading to vascular brain injury (VBI) and neurodegeneration. Objective To identify plasma protein markers of MRI markers of VBI and amyloid- and tau-PET burden in cognitively healthy a...
Martin D. Mulligan, Rui-Qi Wang, Qiong Yang et al.· Journal of Alzheimer's Disea...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.